1. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma
   Marton Tompa et al, 2018, NeuroMolecular Medicine CrossRef
2. To be Wild or Mutant: Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in Gliomagenesis and Treatment Outcome in Glioma
   Bharathan Bhavya et al, 2020, Cellular and Molecular Neurobiology CrossRef
3. Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?
   Anthony Patrizz et al, 2021, Journal of Neuro-Oncology CrossRef
4. In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs
   Safura Pournajaf et al, 2024, Reviews in the Neurosciences CrossRef
5. Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
   Dandan Fan et al, 2021, OncoImmunology CrossRef